Igentify

Evidence

Proven in peer-reviewed clinical research.

Not marketing claims. Published in leading journals and validated in IRB-approved studies. Clinical validation this rigorous is rare in healthcare AI.

Outcomes

The numbers behind the claims

Drawn from peer-reviewed publications and our own deployments. Every figure traces back to a study and a sample size.

Fewer provider interactions

Patient satisfaction

Results clarity

Knowledge transfer

Would recommend to family

Provider time per case

More patients seen

Sources: npj Digital Medicine (2025), ACMG (2023), and Igentify deployment data.

Publications

Peer-reviewed & presented

Published in leading journals and presented at clinical conferences, with full citations and sample sizes.

ACMG Annual Meeting
Publication

Effectiveness of the digital avatar for carrier screening

An IRB-approved carrier-screening study reported 87.2% knowledge transfer, 95% of patients feeling informed enough to decide, and a 4.3/5 satisfaction rating.

ACMG Annual Meeting · 2023
BMJ
Publication

Expanded targeted preconception carrier-screening panel

A 10,115-patient study found pan-ethnic screening identified roughly 4× more at-risk couples than ethnicity-based screening (2.6% vs. 0.7%).

BMJ · 2024

Scale

patients guided through their results and care, at national-lab scale.

Backed by a multi-year enterprise partnership with a leading US national laboratory.

Trust & compliance

Built to the standard of care

A regulated medical device. A familiar anchor for compliance and legal teams.

ISO 13485 certified
ISO 27001 certified
CSA STAR Level One
ISO 27799 certified
ISO 27799
Health informatics security
HIPAA
US health data privacy
GDPR
EU data protection

EU recognition

Three EU Horizon 2020 Seals of Excellence

Independent European Commission review awarded Igentify a Seal of Excellence on three proposals. View or download each certificate.

Put the evidence to work.

See how these outcomes translate to your indications and patients.